Magnesium Sulphate for Treatment of New Onset Atrial Fibrillation in Medical Intensive Care Unit Patient
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of Magnesium sulphate for the rate and
rhythm control of the new onset (within 48 hours) atrial fibrillation in the hemodynamically
unstable patients, admitted in the medical intensive care unit patients.